Organometallics
Article
NMR (282.4 MHz, dmso-d6, 20 °C, δ): −114.2 (s, br, 2o-F), −158.5
(t, 1p-F), −162.8 (m, 2m-F); at 55 °C, −113.8 (s, 2o-F), −159.4 (t,
1p-F), −163.6 (m, 2m-F).
0.57 V (vs Ag/AgCl) (more waves due to electrogenerated by
products are seen at higher potentials).
Preparation of [Pt(bzq-κN,κC10)(C6F5)X2(dmso)] (X = Cl (7a), I
(7b), Br (7c)). General Procedure. A suspension of [{Pt(bzq-
κN,κC10)(C6F5)X(μ-X)}2] (5) in 2 mL of dmso was heated to 50 °C
for 5 min and stirred until complete dissolution of the corresponding
complex. The solution was poured into 400 mL of H2O, and the
obtained precipitate was filtered to give 7.
Data for [{Pt(bzq-κN,κC10)(C6F5)I(μ-I)}2] (5b). [Pt(bzq-κN,κC10)-
(C6F5)(CH3COCH3)] (2; 0.100 g, 0.167 mmol) and I2 (0.042 g,
0.167 mmol) were used (yield of 5b: 0.107 g, 80%). IR (cm−1): ν(C−
F) 1071 (s), 967 (s); ν(C6F5)X‑sens 792 (m), 770 (m); ν(Pt−I) 225
(w), 220 (w). Anal. Calcd for C38H16I4F10N2Pt2: C, 28.74; H, 1.02; N,
1.76. Found: C, 28.56; H, 0.98; N, 1.46. MALDI-TOF (+): m/z (%)
Data for [Pt(bzq-κN,κC10)(C6F5)Cl2(dmso)] (7a). Starting from
[{Pt(bzq-κN,κC10)(C6F5)Cl(μ-Cl)}2] (5a; 0.050 g, 0.041 mmol), 7a
was obtained as a pale yellow solid (0.046 g, 82%). IR (cm−1): ν(C−
F) 1073 (s), 970 (s); ν(C6F5)X‑sens 798 (m); ν(Pt−Cl) 349 (m), 325
(w). Anal. Calcd for C21H14Cl2F5NOPtS: C, 36.59; H, 2.05; N, 2.03; S,
4.65. Found: C, 36.10; H, 2.19; N, 2.26; S, 3.97. MALDI-TOF (−):
m/z (%) 646 [M − dmso + Cl]− (100), 610 [M − dmso]− (35), 576
1
1461 [M − I]+ (9). H NMR (400.1 MHz, dmso-d6, 20 °C, δ): 9.26
(d, J = 5.6, JPt−H = 20, H2, bzq), 8.69 (d, J = 7.9, H4, bzq), 8.01 − 7.94
(m, H3, H5, H6, bzq), 7.57 (d, J = 7.7, H7, bzq), 7.50 (t, J = 7.7, H8,
3
bzq), 7.08 (dd, J = 7.7, JPt−H = 36, H9, bzq). 19F NMR (282.4 MHz,
dmso-d6, 20 °C, δ): −99.5 (s, 1o-F), −104.7 (s, 1o-F), −159.2 (t, 1p-
F), −162.3 (m, 1m-F), −163.7 (m, 1m-F).
1
[Pt(bzq)(C6F5)Cl]− (62). H NMR (400.1 MHz, CD3COCD3, −30
Data for [{Pt(bzq-κN,κC10)(C6F5)Br(μ-Br)}2] (5c). [Pt(bzq-κN,κC10)-
(C6F5)(CH3COCH3)] (2; 0.100 g, 0.167 mmol) and Br2 (9 μL, 0.167
mmol) were used (5c: 0.087 g, 74%). IR (cm−1): ν(C−F) 1074 (s),
967 (s); ν(C6F5)X‑sens 795 (s); ν(Pt−Br) 268 (m), 248, 234 (m). Anal.
Calcd for C38H16Br4F10N2Pt2: C, 32.67; H, 1.16; N, 2.01. Found: C,
32.05; H, 1.31; N, 2.00. MALDI-TOF (+): m/z (%) 1321 [M − Br]+
(22). 1H NMR (400.1 MHz, dmso-d6, 20 °C, δ): 9.29 (d, J = 5.2, JPt−H
= 19, H2, bzq), 8.81 (d, J = 7.9, H4, bzq), 8.01 − 7.94 (m, H3, H5, H6,
bzq), 7.75 (d, J = 7.8, H7, bzq), 7.58 (t, J = 7.7, H8, bzq), 7.16 (m,
3JPt−H = 38.9, H9, bzq). 19F NMR (282.4 MHz, dmso-d6, 20 °C, δ):
−107.3 (s, br, 1o-F), −112.3 (s, br, 1o-F), −159.0 (t, 1p-F), −163.1
(m, 2m-F).
°C, cis:trans isomers ∼1:1.5, δ): cis-7a(dmso-κS) 9.42 (d, J = 5.0, H2,
bzq), 8.81 (d, J = 8.6, H4, bzq), 8.10 (m, 3H, H5, H6, H3, bzq), 7.82 (t,
J = 8.0, H8, bzq), 7.59 (d, J = 7.3, H7, bzq), 7.32 (t, J = 8.4, JPt−H = 39,
H9, bzq), 3.09 (s, 3H, CH3, dmso), 3.03 (s, 3H, CH3, dmso); trans-
7a(dmso-κO) 9.40 (d, J = 5.1, H2, bzq), 8.85 (d, J = 8.1, H4, bzq),
8.15−8.04 (m, 3H, H5, H6, H3, bzq), 7.82 (t, J = 8.0, H8, bzq), 7.59 (d,
J = 7.3, H7, bzq), 7.32 (t, J = 8.4, J
= 39, H9, bzq), 2.54 (s, 6H,
Pt−H
dmso). When the temperature was increased, the two Me signals of
the cis isomer broadened and averaged into one at 3.05 ppm. 19F NMR
(376.5 MHz, CD3COCD3, −50 °C, δ): cis-7a(dmso-κS) −112.2 (d,
JPt‑oF = 102, 1o-F), −119.0 (d, JPt‑oF = 105, 1o-F), −160.8 (t, 1p-F),
−164.1 (m, 1m-F), −165.1 (m, 1m-F); trans-7a(dmso-κO) −112.6 (d,
JPt‑oF = 104, 1o-F), −117.6 (d, JPt‑oF = 116, 1o-F), −161.0 (t, 1p-F),
−164.4 (m, 1m-F), −166.0 (m, 1m-F). 19F NMR (25 °C, δ): −115.0
(br), −161.6 (t, p-F, trans), −161.9 (t, p-F, cis), −165.5 (m, br, m-F,
trans), −165.9 (m, br, m-F, cis).
Preparation of [bzq-CHC(Cl)Fc] (6a). To a cooled (0 °C)
solution of [Pt{bzq-κN-η2-CHC(Cl)Fc}(C6F5)Cl] (4a; 0.129 g,
0.157 mmol) in CH2Cl2 (20 mL) was added 2 equiv of
triphenylphosphine (0.082 g, 0.314 mmol). After 1 h of stirring, the
solvent was removed and the residue treated with Et2O (20 mL),
giving a solid which was filtered and identified as trans-[Pt(C6F5)Cl-
(PPh3)2] (0.040 g, 28%). The orange filtrate was concentrated to a
small volume (2 mL) and purified by column chromatography (SiO2,
n-hexane/CH2Cl2 8/2) to give 6a as an orange solid (0.021 g, 32%).
IR (cm−1): ν(CC) 1374 (s). MALDI-TOF (+): m/z (%) 423 [M]+
(100). Anal. Calcd for C25H18ClFeN: C, 70.87; H, 4.28; N, 3.31.
Data for [Pt(bzq-κN,κC10)(C6F5)I2(dmso)] (7b). Starting from
[{Pt(bzq-κN,κC10)(C6F5)I(μ-I)}2] (5b; 0.040 g, 0.025 mmol), 7b
was obtained as an orange solid (0.039 g, 88%). IR (cm−1): ν(C−F)
1066 (m), 967 (m); ν(C6F5)X‑sens 791 (m); ν(Pt−I) 247 (w), 224 (w).
Anal. Calcd for C21H14I2F5NOPtS: C, 28.92; H, 1.62; N, 1.61; S, 3.68.
Found C, 28.39; H, 0.97; N, 1.71; S, 3.08. MALDI-TOF (−): m/z (%)
667 [Pt(bzq)(C6F5)I]− (100). MALDI-TOF (+): m/z (%) 744 [M −
I]+ (17). 1H NMR (400.1 MHz, CD3COCD3, −50 °C, cis:trans
isomers ∼1:1, δ): cis-7b(dmso-κS) 9.47 (d, J = 6.0, H2, bzq), 8.75 (d, J
= 8.1, H4, bzq), 8.15−8.05 (m, 3H, H5, H6, H3, bzq), 7.66−7.57 (m,
1
Found: C, 70.41; H, 3.89; N, 3.52. H NMR (400.1 MHz, CDCl3, 20
°C, δ): 9.12 (dd, J = 4.2, J = 1.6, H2, bzq), 8.31 (s, 1H, bzq-CH
CFcCl), 8.19 (d, J = 8, H4, bzq), 7.96 (d, J = 7.9, H7/9, bzq), 7.92 (d, J
= 7.9, H7/9, bzq), 7.85 (d, J = 8.8, H5/6, bzq), 7.73 (t, J = 7.9, H8, bzq),
7.70 (d, J = 8.8, H5/6, bzq), 7.53 (dd, J = 4.2, J = 8.1, H3, bzq), 4.83 (s,
2H, C5H4), 4.36 (s, 2H, C5H4), 4.30 (s, 5H, Cp). 13C{1H} NMR
(100.6 MHz, CDCl3, 20 °C, δ): 148.0 (s, C12, bzq), 147.5 (s, C2, bzq),
135.5 (s, C4, bzq), 134.8 (s, =C(Cl)Fc), 131.2 (s, C7/9, bzq), 129.2 (s,
bzq), 128.7 (s, C5/6, bzq), 128.0 (s, C7/9, bzq), 127.7 (s, bzq), 127.3 (s,
C8, bzq), 127.1 (s, CHC(Cl)Fc), 126.7 (s, bzq), 125.6 (s, C5/6, bzq),
121.1 (s, C3, bzq), 69.7 (s, 5C, Cp), 69.1 (s, 2C, C5H4), 67.3 (s, 2C,
C5H4). E1/2 = 0.55 V (vs Ag/AgCl) (more waves due to
electrogenerated by products are seen at higher potentials).
2H, H7, H8, bzq), 7.23 (d, J = 7.5, J
= 37, H9, bzq), 3.16 (s, 3H,
Pt−H
CH3, dmso), 2.99 (s, 3H, CH3, dmso); trans-7b(dmso-κO) 9.44 (d, J
= 5.1, H2, bzq), 8.78 (d, J = 8.0, H4, bzq), 8.15−8.05 (m, 3H, H5, H6,
H3, bzq), 7.66−7.57 (m, 2H, H7, H8, bzq), 7.29 (d, J = 7.2, JPt−H = 39,
H9, bzq), 2.53 (s, 6H, CH3, dmso). When the temperature was
increased, the two Me signals of the cis isomer broadened and averaged
into one at 3.06 ppm. 19F NMR (376.5 MHz, CD3COCD3, −50 °C,
δ): cis-7b(dmso-κS) −100.2 (d, JPt‑oF = 111, 1o-F), −106.4 (d, JPt‑oF
122, 1o-F), −160.9 (t, 1p-F), −163.7 (m, 1m-F), −165.1 (m, 1m-F);
trans-7b(dmso-κO) −101.1 (d, JPt‑oF = 107, 1o-F), −105.1 (d, JPt‑oF
=
=
Preparation of [bzq-CHC(I)Fc] (6b). Following the same
procedure as that for 6a, starting from [Pt{bzq-κN-η2-CHC(I)Fc}-
(C6F5)I] (4b; 0.093 g, 0.093 mmol) and PPh3 (0.049 g, 0.186 mmol),
6b was obtained as an orange solid after purification by column
chromatography (SiO2, n-hexane/CH2Cl2 8/2) (0.014 g, 29%). IR
(cm−1): ν(CC) 1374 (s). MALDI-TOF (+): m/z (%) 515 [M]+
(82), 388 [M − I]+ (100). Anal. Calcd for C25H18IFeN: C, 58.29; H,
126, 1o-F), −161.2 (t, 1p-F), −164.1 (m, 1m-F), −165.9 (m, 1m-F).
19F NMR (25 °C, δ): −99.5 (s, br, o-F, cis), −100.7 (s, br, o-F, trans),
−161.9 (t, p-F, cis + trans), −164.8 (m, br, m-F, cis + trans), −166.0,
−166.4 (m, br, m-F, cis + trans).
Data for [Pt(bzq-κN,κC10)(C6F5)(dmso)Br2] (7c). Starting from
[{Pt(bzq-κN,κC10)(C6F5)Br(μ-Br)}2] (5c; 0.050 g, 0.036 mmol), 7c
was obtained as a pale yellow solid (0.044 g, 79%). IR (cm−1): ν(C−
F) 1077 (m), 971 (m); ν(C6F5)X‑sens 793 (m); ν(Pt−Br) 268 (w), 232
(w). Anal. Calcd for C21H14Br2F5NOPtS: C, 32.41; H, 1.81; N, 1.80; S,
4.12. Found: C, 32.13; H, 1.51; N, 2.32; S, 3.75. MALDI-TOF (−):
m/z (%) 779 [M]− (25), 770 [M − dmso]− (10), 620 [M − dmso −
1
3.52; N, 2.72. Found: C, 57.91; H, 3.29; N, 2.51. H NMR (400.1
MHz, CD3COCD3, 20 °C, δ): 9.16 (dd, J = 4.3, J = 1.4, H2, bzq), 8.39
(d, J = 8.1, H4, bzq), 8.19 (s, 1H, bzq-CHCFcI), 8.05 (m, H8, bzq),
7.98 (d, J = 8.7, H5/6, bzq), 7.86 (d, J = 8.7, H5/6, bzq), 7.78−7.73 (m,
2H, H7, H9, bzq), 7.67 (m, H3, bzq), 4.86 (s, 2H, C5H4), 4.44 (s, 2H,
C5H4), 4.31 (s, 5H, Cp). 13C{1H} NMR (100.6 MHz, CD3COCD3, 20
°C, δ) 148.5 (s, C12, bzq), 147.9 (s, C2, bzq), 137.3 (s, =C(I)Fc), 135.8
(s, C4, bzq), 131.2 (s, C7/9, bzq), 130.5 (s, bzq), 128.4 (s, C5/6, bzq),
128.3 (s, C8, bzq), 127.1 (s, C7/9, bzq), 126.8 (s, bzq), 126.0 (s, CH
C(I)Fc), 125.8 (s, C5/6, bzq), 123.5 (s, bzq), 121.5 (s, C3, bzq), 69.7
1
Br]− (100). H NMR (400.1 MHz, CD3COCD3, −50 °C, cis:trans
isomers ∼2:1, δ): cis-7c(dmso-κS) 9.46 (d, J = 5.2, JPt−H = 18, H2,
bzq), 8.82 (d, J = 7.8, H4, bzq), 8.08 (m, 3H, H3, H5, H6, bzq), 7.76 (d,
J = 8.0, H7, bzq), 7.59 (t, J = 8.0, H8, bzq), 7.29 (d, J = 7.1, JPt−H = 35,
H9, bzq), 3.15 (s, 3H, CH3, dmso), 3.01 (s, 3H, CH3, dmso); trans-
7c(dmso-κO) 9.42 (d, J = 5.2, JPt−H = 17, H2, bzq), 8.85 (d, J = 7.9,
H4, bzq), 8.17 (t, J = 5.5, H3, bzq), 8.16 (m, H5, H6, bzq), 7.77 (d, J =
(s, 5C, Cp, Fc), 69.3 (s, 2C, C5H4, Fc), 68.9 (s, 2C, C5H4, Fc). E1/2
=
3950
dx.doi.org/10.1021/om4004384 | Organometallics 2013, 32, 3943−3953